The FDA has fallen weeks behind schedule in responding to select NDA's and PDUFA's. While people across the globe continue to fall ill, suffer and die from disease and debilitations, American drug research and development companies such as Cell Therapeutics (NASDAQ:CTIC), Hemispherx Biopharma (AMEX:HEB), BioDelivery Sciences International (NASDAQ:BDSI), Discovery Laboratories (NASDAQ:DSCO), Acura Phamaceuticals (NASDAQ:ACUR), King Pharmaceuticals (NYSE:KG) and Genta (OTC:GNTA) sit by anxiousl... Read More

0 comments View Entry

One investor and member of the NVestorz.com community wrote, in regards to the upcoming reverse split vote for Genta, Inc. (OTC:GNTA) - "What are the possibilities for after the vote? I’ve haven’t seen what happens after a reverse stock split. I read that it doesn’t treat the stockholder very well."

There can be only two answers to the reverse split decision:

Vote 'No' and the company has threatened that it "may" have to file for bankruptcy. This isn't good for any of the... Read More

0 comments View Entry